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In this article we present a case of a patient who received reversal of anticoagulation therapy with 
factor IX in violation of hospital guidelines. As a direct result, myocardial infarction and ischemic 
stroke occurred, leaving the patient neurologically debilitated. Factor IX is indicated in the setting 
of warfarin-induced, life-threatening bleeding. The patient’s care was provided by an intern with 
attending physician supervision. Delayed charting and questionable shared decision-making were 
present in the care. We discuss usage of factor IX, liability for supervision of physicians in training, 
and factors that can lead to plaintiff awards. [Clin Pract Cases Emerg Med. 2020;4(1):12–15]
CASE PRESENTATION
A 54-year-old woman presented to her primary care 
physician complaining of epistaxis, hematochezia, headache, 
and a seizure. She had a prior history of seizures. The patient 
was on warfarin for an unknown reason. Her physician 
ordered an international normalized ratio (INR), which 
returned with a result of 13.4 after the patient had gone home. 
She had been told to hold her warfarin during her office visit. 
The patient was directed to go immediately to the emergency 
department (ED) but did not present until the next day. She 
had a history of very labile INRs in the past, with and without 
compliance. Multiple prior ED visits with extremely high 
levels in the past had been treated successfully with vitamin K 
and fresh frozen plasma (FFP) without complications. 
On presentation to the ED the patient complained of a 
headache. She had no epistaxis or evidence of nasal bleeding. 
Her skin exam was normal. A neurologic exam was normal. 
A rectal exam was heme negative and the stool was normal 
color. The patient had right lower abdominal pain and 
tenderness. The emergency physician (EP) attending who 
was board certified in emergency medicine (EM) (seven 
years experience) supervised an intern (who had just begun 
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residency training) in rendering patient care. A computed 
tomography (CT) of the brain was done with normal results. 
An INR lab test returned with a result of greater than 10. 
Due to abdominal tenderness, the possibility of appendicitis 
was entertained. A CT of the abdomen was ordered and the 
surgical service consulted. 
The attending EP then discussed the case with the intern 
and a decision was made to give Profilnine (factor IX). 
There was no documentation of medical decision-making or 
discussion with the patient. The decision to administer factor 
IX was made prior to completion of the surgical consultation 
or CT result. Subsequently the EP attending left for home 
before the patient’s consultation or care was completed. He 
had never administered the drug before and instructed the 
intern to look up the dose on the Internet and order it. A 
hospital guideline specifically discussed indications for use 
of the drug: The patient must have either (1) a serious or life-
threatening bleed; or (2) require emergency surgery.
Three hours after administration of the medication the 
patient developed signs and symptoms of an acute myocardial 
infarction (MI). An electrocardiogram showed marked ST 
elevations, which resolved after the administration of tPA. 
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Troponin was elevated as well. Cardiac catheterization 
performed after resolution of the ST-segment elevation 
revealed no thrombosis. The patient suffered a cardiac 
arrest and was subsequently resuscitated. Experts opined 
that a stroke had also occurred.1 She was left in a minimally 
conscious state with a seven-year life expectancy. A jury 
rendered a plaintiff verdict for $15 million.
DISCUSSION
Dr. Gannon: Caveats when Using Profilnine
Profilnine is the brand name for factor IX complex 
composed of factors II, IX, X. It has notably low or even 
nontherapeutic levels of factor VII and thus should not 
be confused with prothrombin complex concentrate.  The 
primary indications for use are in patients diagnosed with 
a factor IX deficiency, also known as hemophilia B or 
Christmas disease. It is indicated in these patients when 
they present with acute hemorrhage, prophylaxis for 
bleeding, or in preparation for planned surgical or dental 
procedures.2 Dosing is based both on weight and goal of 
factor IX level, which in turn is dependent on the severity 
and/or risk of further bleeding. The cost of factor IX 
complex is per unit and current available pricing is $1.57 
per unit. In a typical 70 kilogram (kg) patient receiving 
the 75-90 units/kg recommended for treatment of major 
bleeding, the price for factor IX complex would amount to 
$8,242.50–$9,891.00.3 
Known adverse effects from factor IX complex 
include antibody formation to factor IX, hypersensitivity 
reactions, thrombotic events, and disseminated intravascular 
coagulation. While there are no contraindications listed in the 
manufacturer’s labeling, caution is advised when using factor 
IX complex in patients with liver disease, history of coronary 
artery disease, and disseminated intravascular coagulation 
due to the risk of thromboembolic complications. Factor IX 
complex has also been used in the treatment of life-threatening 
hemorrhage associated with warfarin. It is important to note 
that this use is off-label, and evidence regarding its use for 
reversal of supratherapeutic INR is poor and heavily expert-
opinion based.4  
Current consensus guidelines do not recommend use 
of prothrombin complex concentrates outside of the setting 
of warfarin-associated major bleeding. When it is used for 
this purpose, the concomitant use of FFP or factor VIIa can 
be considered as factor IX complex contains nontherapeutic 
levels of factor VII.5 It has been shown, in a small study, 
to be effective in the treatment of warfarin-associated 
intracranial hemorrhage without a significantly increased 
risk of thromboembolic complications when compared to 
FFP. However, this study did note that reversal with 3-factor 
prothrombin complex concentrate was accompanied by 
thrombotic complications (venous thromboembolism, 
ischemic stroke or MI) in 12.5% of patients.6
Dr. Bell: Medical-Legal Liability of Residents
Between 2009-2013, EM residents were named in 13.4% 
of malpractice lawsuits.7 In a malpractice lawsuit, four 
elements must be present: duty; breach of duty; causation; 
and damages. This standard holds true for both residents and 
attending physicians who are named in the suit. Malpractice 
cases with residents named were statistically more likely to 
involve cardiac cases and procedures.7 
The vexing issue regarding residents is this: What 
standard of care ought they be held to? Historically, from the 
1950s-1980s, residents were held to a lower standard of care 
than attendings.8 However, this has changed over the years in 
subsequent court rulings. While there is some court variation, 
in general, medical interns, even though they are unlicensed, 
are held to the standard of care of a general practitioner who is 
practicing in a similar setting.8 Residents beyond their intern 
year who are training in a specialty have consistently been 
found to be held to the higher standard of care of an attending 
physicians in that specialty.9,10 In part, this is argued because 
such residents are licensed and are also presenting themselves 
to the patients as specialists in a particular field. While there 
is some possibility that as specialist training progresses, 
residents are held to increasing stricter standards, there is 
some variation in the courts regarding this. 
Although it can occur that EM residents are the sole 
practitioners named in malpractice lawsuits, practically 
speaking this is rare, occurring in only 5.3% of cases between 
2009-2013.11 Hospitals, training institutions, and attendings 
are almost always named in malpractice suits as well.11 With 
some minor variations, the courts have consistently found 
that attending physicians are liable for the residents they are 
supervising, whether that supervision is in person or at a 
distance (direct or indirect).12 
As a malpractice lawsuit progresses it sometimes occurs 
that those named in the suit with greater financial assets 
(“deeper pockets”), such as hospitals and attending physicians, 
are pursued for damages, while residents who may have smaller 
limits on their malpractice insurance are dropped. However, 
residency programs should be encouraged and expected to 
provide appropriate levels of location- and specialty-specific 
malpractice coverage for their trainees. While it is possible for a 
resident to argue that they were poorly trained by their program 
and thus not liable for their malpractice errors, in general such 
arguments have not succeeded.9 
Dr Jackimczyk: Attending Physician Medical-Legal 
Liability for Residents
Two classic legal cases give insight into liability when 
attending physicians supervise residents. In Landry v Leonard, a 
22-year-old woman was referred by her obstetrician to a teaching 
hospital for induction of labor. Upon her arrival a fetal stress 
test was performed by the obstetrical (OB) resident on duty and 
was interpreted as being normal. The test actually demonstrated 
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fetal distress. The baby was subsequently born neurologically 
impaired. The supervising attending OB physician was not 
present at the hospital during the resident’s care of the patient 
but was named in the lawsuit. It was argued that his lack of 
appropriate supervision resulted in the child’s brain damage. Both 
at trial and on appeal the attending obstetrician was dismissed 
because he never came into contact with the patient. Ultimately, 
the case went to the Ohio Supreme Court. 
The patient had signed consent at the teaching hospital 
allowing students to administer treatment but the consent also 
stated that there would be an attending physician delivering 
general instructions. The Ohio Supreme Court ruled that it was 
the attending physician’s duty to be present for the birth rather 
than waiting for the resident to call for help. The Court concluded 
that a physician-patient relationship arises whenever a physician 
consents to act for a patient’s benefit. In teaching hospitals a 
physician-patient relationship may be present when a physician 
agrees to provide supervision in the care of a patient even if they 
have no direct or indirect contact with the patient.13
In Lownsbury v VanBuren, a 23-year-old woman 
presented to the ED with a severe headache. She was 
examined by a resident who ordered a CT of the head. 
He interpreted the CT as normal and performed a lumbar 
puncture, which was normal. The patient was admitted to the 
hospital and was discharged the next day with a diagnosis of 
muscle tension headache. She was never seen and her case 
was never reviewed by the attending physician. She returned 
to the ED the following day with a worsening headache 
and vomiting. She was examined by an attending physician 
who noted decreased vision in her left eye. He reviewed the 
previous day’s CT and noted several small infarcts that the 
resident hadn’t seen. He repeated the head CT and it showed a 
“massive cerebral infarct.” She was admitted to the intensive 
care unit and died three days later. 
A lawsuit was filed and the plaintiffs received damages 
of $500,000, the highest award possible under Louisiana’s 
malpractice law. The plaintiff’s expert witness noted that 
the hospital’s bylaws “bar the medical staff from delegating 
diagnosis and care of patients to practitioners who are 
not qualified to undertake responsibility and who are not 
adequately supervised.” The plaintiff’s verdict was upheld 
on appeal. The attending physician claimed that his lack of 
involvement in the case eliminated his liability. The court 
decided that the attending physician, as supervisor of the 
resident, had accepted a duty to care for the patient and should 
be held responsible for the error in the resident’s judgment. 
The court stated that this is the very reason the attending 
should be present.14
Dr. Moore MD JD: Physician Medical-Legal Mistakes  
Plaintiff attorneys, in the setting of possible 
malpractice, feel very confident in successful litigation 
when hospital guidelines are violated. Guidelines represent 
a consensus opinion and result from a variety of authorities 
agreeing on standard practice. While a physician may 
disagree with the guidelines, and deviate from them in 
certain situations, there should be clear documentation 
of the reasoning behind the deviation.  Conversely, when 
a guideline is followed, plaintiffs admit they have great 
difficulty proving negligence.
The chart in this case was generated three days later by 
the attending and seven days later by the intern. In these cases 
of delayed documentation, when a poor patient outcome 
occurs, juries can be very skeptical of the truthfulness of 
the chart. They recognize the documentation may have self-
serving and litigation-avoiding purposes.
Recently, plaintiff attorneys have begun to point to 
a failure of shared decision-making or lack of informed 
consent when patient outcomes are poor. This is especially 
true when significant and risky treatment decisions are 
undertaken without actual or documented involvement of 
the patient and/or family. A recent randomized controlled 
simulation using clinical vignettes explored the magnitude 
of this issue using no/brief/thorough shared decision-
making. Of 804 participants, patients who received brief or 
thorough shared decision-making were 80% less likely to 
contact a lawyer and expressed higher trust and acceptance 
of adverse outcomes when compared to patients who 
received no decision-making.15
Ignorance of hospital guidelines, delayed charting, and 
lack of shared decision-making all played a significant part in 
this plaintiff outcome of $15 million.
CONCLUSION
Administration of factor IX is a significant medical decision, 
which can lead to severe morbidity or mortality. It is also very 
expensive. It behooves providers to be certain that it is indicated 
before prescribing this therapy.  When supervising others who 
are using this medication, providers must be aware of their 
responsibility and liability for others. Optimal charting and 
information-sharing with patients will reduce liability.Approved 
guidelines that are in place should be respected and the chart 
should reflect specific reasons for deviation.
Take Home Points:
1. Use of factor IX can lead to severe morbidity and 
mortality as well as liability and thus should be given only 
if specifically indicated.
2. When supervising physicians in training, it should be 
realized that although those in training may be held 
liable, the courts have clearly stated that the supervising 
physician has greatest responsibility and liability.
3. Deviation from accepted clinical guidelines exposes 
great liability unless there is clear documentation for the 
thought process and justification that led to the deviation.
4. Delayed charting, when there are bad clinical outcomes, 
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leads to questions of physician honesty by juries when 
trial occurs.
5. Shared decision-making with patients, when there are 
significant clinical decisions to be made, reduces liability 
in resultant negative patient outcomes
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